Nasal Cannula Market Outlook Report | Size, Share & Growth Analysis 2030

[Research Report] The global nasal cannula market was valued at US$ 7,150.00 million in 2022 and is projected to reach US$ 11,717.50 million by 2031. It is expected to register a CAGR of 6.4% in the forecast period.

Market Insights and Analyst View:

A nasal cannula is a medical device used to deliver supplemental oxygen to patients in need. It consists of a thin, flexible tube with two prongs that are inserted into the patient's nostrils. The other end of the tube is connected to an oxygen source, such as an oxygen tank or concentrator. One of the primary advantages of using a nasal cannula is its comfort and ease of use. Patients can continue with their daily activities and even talk while receiving oxygen through the cannula, making it a practical choice for long-term oxygen therapy. It is also a noninvasive method, which means it doesn't require any surgical procedures or puncturing the skin. Nasal cannulas are highly adjustable and can deliver a range of oxygen flow rates, making them suitable for various patient needs. Additionally, they are cost-effective and readily available, making them a preferred option for both healthcare professionals and patients.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

Nasal Cannula Market: Strategic Insights

Nasal Cannula Market

• Market Size 2023
  US$ 7.61 Billion
• Market Size 2031
  US$ 12.50 Billion

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Low Flow Nasal Cannula and High Flow Nasal Cannula

Material

• Plastic and Silicone

End Use

• Hospitals
• Ambulatory Healthcare Services
• Long Term Care Centers

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Growth Drivers and Opportunities:

The nasal cannula market is experiencing significant growth, largely attributed to the increasing geriatric population. As the world's elderly demographic continues to expand, the demand for medical devices like nasal cannulas, which are commonly used for oxygen therapy, is on the rise. These lightweight and comfortable devices are essential for delivering a controlled flow of oxygen to individuals with respiratory conditions, a common concern among the elderly. The convenience and non-invasiveness of nasal cannulas make them a preferred choice for both patients and healthcare providers. This trend is expected to persist as the elderly population continues to grow, driving innovation and advancements in the nasal cannula market to meet the rising demand for effective respiratory care solutions. According to the United Nations, the global median age has changed notably in the last few decades; it increased from 24 in 1950 to 31 in 2021. This indicates that there has been a rise in the elderly population, along with the overall population, in every country. According to the World Health Organization (WHO), estimates published in October 2022, 1 in 6 people worldwide will be aged 60 or above by 2031; the number is further expected to surge from 1 billion in 2021 to 1.4 billion by 2031 and 2.1 billion by 2050. In addition, the number of people aged 80 and above is expected to reach 426 million by 2050.

According to the Population Reference Bureau (PRB), Italy has 23% senior citizens, followed by Finland, Portugal, and Greece, respectively, ranking among the top five European countries with the highest percentage of geriatric population. 22% of the total population in Finland, Portugal, and Greece, together, is geriatric population. Croatia, Greece, Italy, Malta, Portugal, Serbia, Slovenia, and Spain collectively accounted for 21% of the total elderly population in Europe. Similarly, in the US, the geriatric population accounts for 16% of its total population.

Furthermore, the rising prevalence of respiratory conditions like asthma is also driving the market growth. For instance, the Asthma and Allergy Foundation of America (AAFA) released numbers in April 2022 indicating that around 1 in 13 Americans, or 25 million people, had asthma in 2021. The same source estimates that 5.1 million children in America under the age of 18 have asthma. Furthermore, women are more likely than men to have asthma (9.8% vs. 6.1%). Furthermore, according to the Centers for Disease Control's (CDC) Interactive Summary of Health Statistics for Adults, 3.5% of adults suffered from asthma in 2021. Thus, patients with respiratory conditions frequently need high-flow oxygen therapy delivered by nasal cannulas, which raises demand for the device and accelerates market expansion.

Report Segmentation and Scope:

The "Global Nasal Cannula Market" is segmented based on type, material, end-use, and region. The type of segment of the nasal cannula market is broadly segmented into low-flow nasal cannula and high-flow nasal cannula. The nasal cannula market is classified on the basis of materials such as plastic and silicone. The end-user segment of the nasal cannula market is broadly segmented into hospitals, ambulatory healthcare services, long-term care centers, and others. The nasal cannula market based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America)

Segmental Analysis:

Based on type, the nasal cannula market is segmented into low-flow nasal cannula and high-flow nasal cannula, denture products, toothbrushes and accessories, mouthwashes/ rinses, dental accessories/ ancillaries, dental prosthesis cleaning solutions, and other dental products. In 2022, the low-flow segment held the largest revenue share and dominated the market. Low-flow nasal cannulas are becoming more and more popular in long-term care, home care, and ambulatory care settings where low or medium concentration is needed and the patient is in a stable state. Furthermore, the low cost encourages adoption even more, which helps the low-flow nasal cannula get a larger market share. Due to the increasing use of high-flow nasal cannulas for respiratory support in critically sick patients, as well as recent advancements that increase its application in home or low-level healthcare settings, the high-flow nasal cannula market is expanding quickly.

Based on material, the nasal cannula market is segmented into plastic and silicon. Due to its low cost and ease of availability, the plastic nasal cannula dominated the market. It held the largest revenue share in 2021, giving patients-including long-term users-more comfort and flexibility. Conversely, silicone-made nasal cannulas are becoming more and more common, particularly among long-term oxygen therapy patients who have allergies to plastic and who get inflammations, skin irritations, and nose irritations.

The nasal cannula market is classified on the basis of end-use, such as hospitals, ambulatory healthcare services, long-term care centers, and others. The hospital's segment held the largest share of the market in 2021, owing to increasing usage of high-flow nasal cannulas for patients with severe respiratory distress requiring high-flow oxygen. In addition, the aging population and patients experiencing chronic respiratory distress are predicted to fuel the expansion of the nasal cannula market segment in long-term care facilities. Because of the increasing number of older adults, the long-term care center market is predicted to rise significantly in the upcoming years. Furthermore, the need for long-term care facilities is anticipated to rise as more people experience chronic respiratory discomfort.

Regional Analysis: 

Based on geography, the global nasal cannula market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

Throughout the forecast period, North America is anticipated to maintain a leading position in the worldwide nasal cannula market. In 2023, North America is projected to account for 33.5% of the market share. The development of new products by major industry players to diversify their product offerings in North America is one of the growing organic growth strategies that are anticipated to propel the nasal cannula market into a considerable expansion in the near future. Movair, a respiratory therapy company that was formerly known as International Biophysics Corporation, announced in October 2021 that Luisa, an advanced ventilator meant for use in homes, institutions, hospitals, or portable applications for both invasive and noninvasive ventilation, would be going on sale in the United States. Luisa also has the special ability to alternate, at the touch of a button, between a noninvasive ventilator (NIV) and a high-flow nasal cannula (HFNC) in various modes.

The Asia Pacific region's need for nasal cannulas is predicted to increase as a result of the growing government initiatives. For instance, the United Nations International Children's Emergency Fund, a nonprofit that was assisting in the installation of nine oxygen-generating plants across hospitals in Gujarat, Arunachal Pradesh, and Tripura, faced a significant challenge in June 2021 as India battled the second wave of COVID-19. This was due to a critical shortage of oxygen for treating patients with respiratory diseases. Hospitals in Arunachal Pradesh, Gujarat, Nagaland, Maharashtra, Meghalaya, and Tripura were to receive the 26 oxygen-generating units. Additionally, 10 Indian states have received 512 High Flow Nasal Cannulas.

Industry Developments and Future Opportunities:

Various initiatives taken by key players operating in the global nasal cannula market are listed below:

• In June 2023, The Breas Medical Vivo 1-2-3 line of bilevel devices and accessories will be distributed in Canada by McArthur Medical Sales, a manufacturing and distribution company, in collaboration with Breas Medical. For non-dependent patients with chronic respiratory insufficiency, the Vivo 1-2-3 product family is a bilevel ventilator that provides both "noninvasive" and invasive (Vivo 3 only) ventilation. The devices provide SpO2 monitoring, a full range of modes with auto-EPAP and high-flow nasal cannula therapy, and an integrated humidifier with a heated wire circuit.
• In April 2021, A significant increase in its capacity to manufacture capital equipment was recently reported by Vapotherm. This medical technology business specializes in the development and marketing of its unique Hi-VNI Technology products, which are used to treat patients with respiratory distress. A sophisticated high-flow nasal cannula (HFNC) system that uses high velocity to treat COVID-19 patients' respiratory distress is called the Precision Flow Hi-VNI system.
• In February 2021, Masimo launched softFlow, a cutting-edge pulmonary care therapy that gives patients who are breathing on their own warm, humidified respiratory gases through their nose high-flow. Through the use of a soft nasal cannula, the technology on the softFlow 50 provides adult patients with high-flow respiratory assistance by producing a steady high flow of warm, humidified air or an air/oxygen mixture.
• In August 2021, The IIT Kanpur incubator business Nocca Robotics Pvt Ltd introduced the Noccarc H210, a high-flow oxygen therapy device. The state-of-the-art tool is user-friendly and pleasant for patients, and it has been demonstrated to be helpful in treating COVID-19 patients. The likelihood of intubation is significantly decreased with high-flow oxygen therapy.

Competitive Landscape and Key Companies:

Some of the prominent players operating in the global nasal cannula market are Allied Healthcare Products Inc., Teleflex Incorporated, Flexicare Medical Ltd., Vapotherm Inc., ResMed Inc.; Fairmont Medical; Fisher & Paykel Healthcare Limited; Well Lead Medical Co. Ltd.; Salter Labs and amongst others. These nasal cannula markets focus on new product launches and geographical expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. They have a widespread global presence, which allows them to serve a large set of customers and subsequently increase their market share. The report offers nasal cannula market trends analysis emphasizing various parameters such as technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.

Nasal Cannula Market Report Scope